2002
DOI: 10.1016/s1044579x02000871
|View full text |Cite
|
Sign up to set email alerts
|

Familial nasopharyngeal carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
69
2
1

Year Published

2004
2004
2021
2021

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 81 publications
(74 citation statements)
references
References 34 publications
2
69
2
1
Order By: Relevance
“…In that study, an average of 4 -5 cases of NPC were observed in each family, and the average age of patients at diagnosis was 35.52 years-much younger than the average age of onset for sporadic cases diagnosed in outpatients at CCSYSU (46.6 years). 35 In the current study, the average age of onset decreased from 44.48 years to 40.43 years as the number of cases of NPC per family increased from 1 to 4, although the absolute trend did not achieve statistical significance. In Taiwan, a moderate-risk area with respect to NPC, a study conducted by Ung et al 30 (involving 25 familial cases and 350 sporadic cases) found no significant difference between familial cases and sporadic cases in terms of age, ethnicity, disease histology, disease stage, or family history of other malignancies.…”
Section: Discussioncontrasting
confidence: 61%
See 2 more Smart Citations
“…In that study, an average of 4 -5 cases of NPC were observed in each family, and the average age of patients at diagnosis was 35.52 years-much younger than the average age of onset for sporadic cases diagnosed in outpatients at CCSYSU (46.6 years). 35 In the current study, the average age of onset decreased from 44.48 years to 40.43 years as the number of cases of NPC per family increased from 1 to 4, although the absolute trend did not achieve statistical significance. In Taiwan, a moderate-risk area with respect to NPC, a study conducted by Ung et al 30 (involving 25 familial cases and 350 sporadic cases) found no significant difference between familial cases and sporadic cases in terms of age, ethnicity, disease histology, disease stage, or family history of other malignancies.…”
Section: Discussioncontrasting
confidence: 61%
“…Although little information on NPC is available in the literature, there is some evidence that other malignancies, such as salivary gland carcinomas and Burkitt lymphoma, may be associated with the development of NPC. 35 However, these malignancies all can be traced to the involvement of EBV in NPC pathogenesis. In the current study, we examined the occurrence of other malignancies in FDRs of probands with NPC in a high-risk subgroup and found no significantly increased risks.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…NPC has a particularly high incidence in Southeast Asia and Northern Africa, with a distinct ethnic predilection (Chou et al, 2008). Accumulating evidence revealed that NPC is a multifactorial malignancy associated with Epstein-Barr virus (EBV) infection, genetic susceptibility and environmental factors (McDermott et al, 2001;Zeng and Jia, 2002;Wei and Sham, 2005;Bei et al, 2010). Although NPC tumors are sensitive to radiotherapy and chemotherapy, the prognosis is poor due to recurrence and metastases.…”
Section: Introductionmentioning
confidence: 99%
“…The disease models underpinning multiple familial cancers such as familial nasopharyngeal carcinoma, 112 familial testicular germ cell tumor, 113 familial chronic lymphocytic leukemia, 114 and familial colorectal cancer (familial colorectal cancer type X) 29 remain contentious as the high-penetrance mutations are yet to be identified. By contrast, multiple low-penetrance variants that confer an effect size of odds ratio o1.5 have been revealed through genome-wide association studies for the sporadic cases of these cancers; interestingly, some of these single-nucleotide polymorphisms have also been found to be associated with the familial cases (nasopharyngeal carcinoma, 115 testicular germ cell tumor, 116,117 chronic lymphocytic leukemia, 118,119 and colorectal cancer 120 ).…”
Section: Perspectives and Conclusionmentioning
confidence: 99%